Sharmila Rao
Senior Consultant at Princeton Capital Advisors- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Hindi -
Topline Score
Bio
Credentials
-
Biostatistics in Public Health
CourseraAug, 2020- Oct, 2024
Experience
-
Princeton Capital Advisors
-
United States
-
Business Consulting and Services
-
1 - 100 Employee
-
Senior Consultant
-
May 2021 - Present
Senior consultant at health and biopharma focused advisory firm. Worked on strategic advisory assignments for small and mid-sized biotechnology, pharmaceutical and medical device companies. Senior consultant at health and biopharma focused advisory firm. Worked on strategic advisory assignments for small and mid-sized biotechnology, pharmaceutical and medical device companies.
-
-
-
Kearney
-
United States
-
Business Consulting and Services
-
700 & Above Employee
-
Associate
-
Feb 2017 - May 2017
Part of a major procurement strategy and implementation project for a multinational medical products and pharmaceutical company. Evaluated product supply chains for procurement of innovative and disruptive technologies. Reviewed industry trends, market dynamics and competitive strategies. Assessed opportunities for improved strategic positioning through long-term partnerships. Developed and completed work products to influence a wide range of stakeholders, including commercial and research & development leaders. Show less
-
-
-
Cello Health
-
United Kingdom
-
Research Services
-
1 - 100 Employee
-
Associate Consultant
-
2005 - 2008
Executed physician and market research for pharmaceutical and biotech companies to assess the therapeutic and commercial potential of novel drugs for treatment of range of cancers. Assessed market gaps and unmet therapeutic treatment needs in a range of cancers. Reviewed ongoing clinical development strategies of competitors, and evaluated total addressable market size for key chemotherapies. Interviewed numerous academic and clinical key opinion leaders across multiple markets to understand patient segmentation, unmet needs, future trends, and likely competitive positions of novel drugs in future treatment strategies. Identified commercially important treatment opportunities for several cancers including Large B-cell Lymphoma (DLBC), Multiple Myeloma (MM), Non-Small Cell Lung Cancer (NSCLC), Hepatocecullar Carcinoma (HCC) and Ovarian Cancer. Show less
-
-
-
Merck
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Financial Analyst
-
Aug 2001 - Nov 2003
Provided financial and strategic planning support for Merck emerging market business units. Involved in corporate strategy development, financial planning, and forecasting in Eastern European, Middle East, and Africa markets. Provided finance and strategic planning as part of a corporate development team involved in an international acquisition. Developed financial forecasts for alternative market scenarios and assessed valuation impacts. Supported regional business unit leadership in reviewing and evaluating capital projects and growth initiatives. Show less
-
-
-
Memorial Sloan Kettering Cancer Center
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Senior Research Fellow
-
1998 - 2000
Lead scientist and project leader in a clinical research project investigating prostate cancer funded by Milken Institute / Prostate Cancer Foundation. Coordinated a multidisciplinary team involving oncologists, cancer surgeons, pathologists, nurses and researchers. Mentored and advised 5 PhD-level graduate students. Lead scientist and project leader in a clinical research project investigating prostate cancer funded by Milken Institute / Prostate Cancer Foundation. Coordinated a multidisciplinary team involving oncologists, cancer surgeons, pathologists, nurses and researchers. Mentored and advised 5 PhD-level graduate students.
-
-
-
New York State Department of Health
-
United States
-
Wellness and Fitness Services
-
700 & Above Employee
-
Postdoctoral Fellow
-
1996 - 1998
Postdoctoral fellow focused on molecular targeting of breast cancers. Discovered potential use of Mevacor (Lovastatin) in preventing breast cancer cell proliferation. Results were published in Proceeding of the National Academy of Sciences. Published 4 papers in top 10 science journals, managed laboratory research team under a multi-year US Army grant. Postdoctoral fellow focused on molecular targeting of breast cancers. Discovered potential use of Mevacor (Lovastatin) in preventing breast cancer cell proliferation. Results were published in Proceeding of the National Academy of Sciences. Published 4 papers in top 10 science journals, managed laboratory research team under a multi-year US Army grant.
-
-
Education
-
Cornell University - Johnson Graduate School of Management
Master of Business Administration (M.B.A.), Business Strategy and Finance -
The Graduate Center, City University of New York
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology -
St. Xavier's College
Bachelor of Science - BS, Biochemistry and Molecular Biology